BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33067756)

  • 1. Feasibility and validity of EQ-5D-5L proxy by nurses in measuring health-related quality of life of nursing home residents.
    Toh HJ; Yap P; Wee SL; Koh G; Luo N
    Qual Life Res; 2021 Mar; 30(3):713-720. PubMed ID: 33067756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Empirical Comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a Post-Hospitalisation Population of Frail Older People Living in Residential Aged Care.
    Ratcliffe J; Flint T; Easton T; Killington M; Cameron I; Davies O; Whitehead C; Kurrle S; Miller M; Liu E; Crotty M
    Appl Health Econ Health Policy; 2017 Jun; 15(3):399-412. PubMed ID: 27882528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in people with advanced dementia: a comparison of EQ-5D-5L and QUALID instruments.
    Sopina E; Chenoweth L; Luckett T; Agar M; Luscombe GM; Davidson PM; Pond CD; Phillips J; Goodall S
    Qual Life Res; 2019 Jan; 28(1):121-129. PubMed ID: 30187395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.
    Easton T; Milte R; Crotty M; Ratcliffe J
    Qual Life Res; 2018 May; 27(5):1283-1294. PubMed ID: 29305782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
    Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
    Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
    Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
    Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
    Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
    Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring health-related quality of life of care home residents: comparison of self-report with staff proxy responses.
    Usman A; Lewis S; Hinsliff-Smith K; Long A; Housley G; Jordan J; Gage H; Dening T; Gladman JRF; Gordon AL
    Age Ageing; 2019 May; 48(3):407-413. PubMed ID: 30615057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
    Fitriana TS; Purba FD; Stolk E; Busschbach JJV
    Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form.
    Lin FJ; Pickard AS; Krishnan JA; Joo MJ; Au DH; Carson SS; Gillespie S; Henderson AG; Lindenauer PK; McBurnie MA; Mularski RA; Naureckas ET; Vollmer WM; Lee TA;
    BMC Med Res Methodol; 2014 Jun; 14():78. PubMed ID: 24934150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring health-related quality of life of care home residents, comparison of self-report with staff proxy responses for EQ-5D-5L and HowRu: protocol for assessing proxy reliability in care home outcome testing.
    Usman A; Lewis S; Hinsliff-Smith K; Long A; Housley G; Jordan J; Gage H; Dening T; Gladman JRF; Gordon AL
    BMJ Open; 2018 Aug; 8(8):e022127. PubMed ID: 30121605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
    Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
    Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construct validity of EQ-5D-5L among patients with inflammatory bowel disease-a study based on real-world data from the Swedish Inflammatory Bowel Disease Registry.
    Latteur J; Ernstsson O; Nilsson E; Jäghult S; Heintz E
    J Patient Rep Outcomes; 2024 Mar; 8(1):39. PubMed ID: 38536626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
    Yfantopoulos J; Chantzaras A; Kontodimas S
    Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the EQ-5D-5L questionnaire among the general population of Poland.
    Młyńczak K; Golicki D
    Qual Life Res; 2021 Mar; 30(3):817-829. PubMed ID: 33099710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.